Company intelligence / Profile preview

Castel

Friendswood, Texas, United States

Ownership: Private
Employees: ~501
Development stage: Other

Overview

Castle Biosciences offers a portfolio of commercial and pipeline molecular diagnostic tests, including DecisionDx®-Melanoma and DecisionDx®-SCC. Its tests are supported by >150 peer-reviewed publications and are broadly adopted in clinical care.

Therapeutic areas: OncologyGastroenterology
Modalities: Gene expression profilingMolecular diagnostics
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Castel.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Castel.

Explore the full profile